A clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sjögren’s syndrome

OBJECTIVE: To elucidate the clinical values of anti-M3R in Sjögren’s syndrome (SS) in the largest cohort for an anti-M3R study. METHODS: The plasma of 361 subjects (156 primary-SS[pSS], 62 non-SS-sicca[SICCA], 40 systemic lupus erythematosus [SLE], 50 rheumatoid arthritis[RA], and 53 healthy control...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Exp Rheumatol
Prif Awduron: Mona, Mahmoud, Mondello, Stefania, Hyon, Joon Young, Saleh, Wafaa, Han, Kyudong, Lee, Hyo-Jung, Ha, You-Jung, Kang, Eun Ha, Lee, Yun Jong, Cha, Seunghee
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8021605/
https://ncbi.nlm.nih.gov/pubmed/33124573
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg